At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Sep 9, 2026 at 16:02 ET
A cluster of insider selling at Artiva Biotherapeutics, totaling $477K, was driven by the CEO, COO, CTO, and CMO. The CEO's $256K sale is the largest, but the total represents only ~0.09% of the $509M market cap, falling below the 0.1% materiality threshold. This is a routine, low-significance event, especially given the simultaneous large equity grants to the same executives, which are non-cash and likely set up a 10b5-1 plan for tax or diversification purposes.
- Total insider selling of $477K represents ~0.09% of ARTV's $509M market cap, below the 0.1% materiality threshold.
- CEO Fred Aslan sold 23,429 shares for $256K on 2026-09-08, the largest single trade in the cluster.
- COO Jennifer Bush, CTO Christopher Horan, and CMO Subhashis Banerjee also sold shares totaling $222K on 2026-09-03.
- All four selling insiders received large equity grants on 2026-09-09 (non-cash, $0 value), suggesting the sales may be liquidity-driven to cover taxes or diversify after vesting.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access